Is it necessary to get the 9-valent HPV vaccine after receiving the 2-valent HPV vaccine?

The bivalent HPV vaccine generally does not require follow-up vaccination with the nonavalent HPV vaccine.

The bivalent HPV vaccine protects against HPV types 16 and 18, the two subtypes directly responsible for cervical cancer. According to relevant statistics, about 70% of cervical cancer cases are associated with these two virus types. Although the nonavalent HPV vaccine offers protection against more virus types and provides broader preventive coverage, the majority of HPV infections leading to cervical cancer in women are still caused by types 16 and 18. Therefore, there is no need to receive the nonavalent HPV vaccine after completing the bivalent HPV vaccine series. The bivalent HPV vaccine also has synergistic effects against other virus types. HPV vaccines are most effective when administered before the onset of sexual activity.

Married women or those with a history of sexual activity should undergo annual cervical cancer screening, including TCT testing and HPV testing. If any abnormalities are detected, prompt treatment is essential. It is recommended that patients avoid smoking and alcohol consumption, maintain a healthy lifestyle, avoid high-risk sexual behaviors, and pay attention to perineal hygiene. Additionally, it is important to actively treat gynecological conditions such as chronic cervicitis and fungal infections, and to strengthen overall immunity.